Clinical Trial Update: Mozobil for Autologous Stem Cell Mobilization [Phase 2]

View source ↗

Summary

Phase 2 trial update for Mozobil (plerixafor) assessing autologous stem cell mobilization has completed in Non-Hodgkin's Lymphoma and Hodgkin's Lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Mozobil (plerixafor)

Snippet

Sponsor: Sheba Medical Center | Conditions: Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED